AdaptHealth (NASDAQ:AHCO) Price Target Raised to $28.00 at Deutsche Bank Aktiengesellschaft

AdaptHealth (NASDAQ:AHCOGet Rating) had its price objective raised by Deutsche Bank Aktiengesellschaft from $26.00 to $28.00 in a report issued on Tuesday morning, The Fly reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

Other equities research analysts also recently issued reports about the stock. Truist Financial lifted their price target on shares of AdaptHealth from $26.00 to $28.00 and gave the stock a buy rating in a report on Monday. TheStreet upgraded shares of AdaptHealth from a d+ rating to a c- rating in a report on Tuesday, August 2nd. Finally, SVB Leerink lifted their price target on shares of AdaptHealth from $24.00 to $29.00 and gave the stock an outperform rating in a report on Wednesday, August 10th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of Buy and an average target price of $27.17.

AdaptHealth Stock Performance

NASDAQ:AHCO opened at $21.71 on Tuesday. The company has a current ratio of 1.39, a quick ratio of 1.15 and a debt-to-equity ratio of 1.02. The firm has a 50-day moving average price of $20.90 and a two-hundred day moving average price of $18.08. AdaptHealth has a twelve month low of $11.40 and a twelve month high of $28.75. The company has a market capitalization of $2.92 billion, a P/E ratio of 41.75, a price-to-earnings-growth ratio of 0.32 and a beta of 0.59.

AdaptHealth (NASDAQ:AHCOGet Rating) last posted its earnings results on Tuesday, August 9th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.23). AdaptHealth had a net margin of 4.91% and a return on equity of 6.49%. The business had revenue of $727.61 million for the quarter, compared to analysts’ expectations of $724.27 million. During the same quarter last year, the business posted ($0.11) earnings per share. The business’s revenue was up 17.9% compared to the same quarter last year. As a group, research analysts expect that AdaptHealth will post 1.37 earnings per share for the current fiscal year.

Insider Buying and Selling at AdaptHealth

In other AdaptHealth news, major shareholder Everest Hill Group Inc. sold 159,000 shares of AdaptHealth stock in a transaction that occurred on Wednesday, August 10th. The shares were sold at an average price of $23.00, for a total transaction of $3,657,000.00. Following the transaction, the insider now directly owns 15,485,834 shares of the company’s stock, valued at $356,174,182. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, General Counsel Christopher J. Joyce sold 100,000 shares of the business’s stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $22.20, for a total transaction of $2,220,000.00. Following the transaction, the general counsel now directly owns 106,071 shares of the company’s stock, valued at $2,354,776.20. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, major shareholder Everest Hill Group Inc. sold 159,000 shares of the business’s stock in a transaction on Wednesday, August 10th. The stock was sold at an average price of $23.00, for a total transaction of $3,657,000.00. Following the transaction, the insider now directly owns 15,485,834 shares in the company, valued at $356,174,182. The disclosure for this sale can be found here. Insiders have sold a total of 474,382 shares of company stock valued at $10,938,477 over the last ninety days. Corporate insiders own 17.29% of the company’s stock.

Institutional Trading of AdaptHealth

A number of hedge funds and other institutional investors have recently made changes to their positions in AHCO. Nisa Investment Advisors LLC increased its stake in shares of AdaptHealth by 96.6% in the first quarter. Nisa Investment Advisors LLC now owns 1,710 shares of the company’s stock worth $27,000 after buying an additional 840 shares during the last quarter. Covestor Ltd bought a new stake in AdaptHealth during the fourth quarter valued at $35,000. US Bancorp DE increased its stake in AdaptHealth by 121.7% during the second quarter. US Bancorp DE now owns 2,614 shares of the company’s stock valued at $48,000 after purchasing an additional 1,435 shares during the last quarter. Group One Trading L.P. increased its stake in AdaptHealth by 134.3% during the first quarter. Group One Trading L.P. now owns 3,720 shares of the company’s stock valued at $60,000 after purchasing an additional 2,132 shares during the last quarter. Finally, Advisor Group Holdings Inc. increased its stake in AdaptHealth by 306.5% during the fourth quarter. Advisor Group Holdings Inc. now owns 3,000 shares of the company’s stock valued at $73,000 after purchasing an additional 2,262 shares during the last quarter. Institutional investors own 75.76% of the company’s stock.

AdaptHealth Company Profile

(Get Rating)

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Featured Stories

The Fly logo

Analyst Recommendations for AdaptHealth (NASDAQ:AHCO)

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.